Walgreens Boots Alliance Acquires Remaining Stake in Shields Health Solutions

Welsh, Carson, Anderson & Stowe and Walgreen Co. Invest in Shields Health Solutions

July 31, 2019

Healthcare Services

Welsh, Carson, Anderson & Stowe (WCAS) and Walgreen Co. (Walgreens) made undisclosed equity investments in Shields Health Solutions to support the company’s national expansion and growth of its integrated specialty pharmacy model. The capital will help Shields expand into new disease states and enhance integrated service and technology offerings while accelerating partnerships with health systems nationwide.

Walgreens Boots Alliance Acquires Majority Stake in CareCentrix

October 14, 2021

Healthcare Services

Walgreens Boots Alliance (WBA) has acquired a majority interest in CareCentrix, investing approximately $330 million for a 55% stake at an $800 million valuation, giving WBA majority ownership. The transaction (now completed) integrates CareCentrix's home-centered care coordination capabilities into WBA's newly launched Walgreens Health segment while CareCentrix continues to operate under its existing leadership.

Sycamore Partners Acquires Walgreens Boots Alliance

August 28, 2025

Healthcare Services

Sycamore Partners, in partnership with Stefano Pessina and his family, completed the acquisition of Walgreens Boots Alliance, taking the company private and separating its businesses to operate as standalone companies. Following the closing, Walgreens, The Boots Group, Shields Health Solutions, CareCentrix and VillageMD will operate independently to pursue focused growth under private ownership.

Henry Schein Acquires Majority Interest in Shield Healthcare

October 17, 2023

Healthcare Services

Henry Schein completed the acquisition of a majority interest in Shield Healthcare, a Valencia, California-based supplier of homecare medical products that had approximately $180 million in 2022 net sales. The current owners, including management, will retain a minority stake; financial terms were not disclosed and Henry Schein expects the deal to be neutral to 2023 non-GAAP EPS and accretive thereafter.

GHO Capital Acquires Majority Stake in Sterling Pharma Solutions

February 28, 2019

Pharmaceuticals

GHO Capital has acquired a majority stake in Sterling Pharma Solutions alongside management. The investment will support Sterling's international expansion and accelerate growth of its specialist API development and GMP manufacturing capabilities from its UK base in Newcastle upon Tyne.

GHO Capital and Partners Group Invest in Sterling Pharma Solutions

May 25, 2023

Pharmaceuticals

GHO Capital (majority owner) and Partners Group have completed an investment into GHO portfolio company Sterling Pharma Solutions, with Partners Group acquiring a significant minority stake. The transaction is supported by a consortium led by funds managed by AlpInvest Partners and Pantheon and will fund Sterling's expansion of production capacity, capability build-out and further strategic acquisitions across the UK, Europe and the US.